Clinical Trial Update: A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a vaccine in combination with beta-glucan and GM-CSF in neuroblastoma patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Vaccine (vaccine)
• β-glucan (beta-glucan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma | Phase 2 | Status: RECRUITING